Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 2491 AL 2505

General Anesthesia and Progression of Parkinson Disease: A Shaky Association

Crosby G, Vutskits L.

Anesth Analg. 2021 Nov 1;133(5):1138-1139. doi: 10.1213/ANE.0000000000005735.

Validation of the Korean version of the composite autonomic symptom scale 31 in patients with Parkinson's disease

Ahn JH, Seok JM, Park J, Jeong H, Kim Y, Song J, Choi I, Cho JW, Min JH, Kim BJ, Youn J.

PLoS One. 2021 Oct 21;16(10):e0258897. doi: 10.1371/journal.pone.0258897. eCollection 2021.

Olfactory loss and aging: connections with health and well-being

Papazian EJ, Pinto JM.

Chem Senses. 2021 Jan 1;46:bjab045. doi: 10.1093/chemse/bjab045.

Patterns of multimorbidity in 4588 older adults: implications for a nongeriatrician specialist

Piotrowicz K, Pac A, Skalska A, Mossakowska M, Chudek J, Zdrojewski T, Więcek A, Grodzicki T, Gąsowski J.

Pol Arch Intern Med. 2021 Dec 22;131(12):16128. doi: 10.20452/pamw.16128. Epub 2021 Oct 22.

Long Non-coding RNAs and Circular RNAs: Insights Into Microglia and Astrocyte Mediated Neurological Diseases

Chen M, Lai X, Wang X, Ying J, Zhang L, Zhou B, Liu X, Zhang J, Wei G, Hua F.

Front Mol Neurosci. 2021 Oct 5;14:745066. doi: 10.3389/fnmol.2021.745066. eCollection 2021.

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease

Li P, Xu P, Liu J.

Front Aging Neurosci. 2021 Oct 5;13:776873. doi: 10.3389/fnagi.2021.776873. eCollection 2021.

The Concept of α-Synuclein Strains and How Different Conformations May Explain Distinct Neurodegenerative Disorders

Malfertheiner K, Stefanova N, Heras-Garvin A.

Front Neurol. 2021 Oct 5;12:737195. doi: 10.3389/fneur.2021.737195. eCollection 2021.

A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019

Jugl S, Okpeku A, Costales B, Morris EJ, Alipour-Haris G, Hincapie-Castillo JM, Stetten NE, Sajdeya R, Keshwani S, Joseph V, Zhang Y, Shen Y, Adkins L, Winterstein AG, Goodin A.

Med Cannabis Cannabinoids. 2021 Feb 25;4(1):21-42. doi: 10.1159/000515069. eCollection 2021 Jun.

Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence

Verma R, Hoda F, Arshad M, Iqubal A, Siddiqui AN, Khan MA, Haque SE, Akhtar M, Najmi AK.

Med Cannabis Cannabinoids. 2021 May 21;4(1):43-60. doi: 10.1159/000515042. eCollection 2021 Jun.

Nuclear receptors of NR1 and NR4 subfamilies in the regulation of microglial functions and pathology

Katsuki H.

Pharmacol Res Perspect. 2021 Dec;9(6):e00766. doi: 10.1002/prp2.766.

What Do We Know about Theory of Mind Impairment in Parkinson's Disease?

Trompeta C, Fernández Rodríguez B, Gasca-Salas C.

Behav Sci (Basel). 2021 Sep 24;11(10):130. doi: 10.3390/bs11100130.

A Systematic Review of Neurofeedback for the Management of Motor Symptoms in Parkinson's Disease

Anil K, Hall SD, Demain S, Freeman JA, Ganis G, Marsden J.

Brain Sci. 2021 Sep 29;11(10):1292. doi: 10.3390/brainsci11101292.

A Proteomic View of Cellular and Molecular Effects of Cannabis

Abyadeh M, Gupta V, Paulo JA, Gupta V, Chitranshi N, Godinez A, Saks D, Hasan M, Amirkhani A, McKay M, Salekdeh GH, Haynes PA, Graham SL, Mirzaei M.

Biomolecules. 2021 Sep 27;11(10):1411. doi: 10.3390/biom11101411.

Structural and Functional Insights into α-Synuclein Fibril Polymorphism

Mehra S, Gadhe L, Bera R, Sawner AS, Maji SK.

Biomolecules. 2021 Sep 28;11(10):1419. doi: 10.3390/biom11101419.

Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson's Disease: Roads to Biomarker Discovery

Picca A, Guerra F, Calvani R, Romano R, Coelho-Júnior HJ, Bucci C, Marzetti E.

Biomolecules. 2021 Oct 13;11(10):1508. doi: 10.3390/biom11101508.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias